Jefferies Maintains a 'Buy' on McGraw-Hill (MHP); Speculation on Wood Mackenzie Cleared Up
Tweet Send to a FriendGet Alerts MHP Hot Sheet
Price: $55.93 +0.59%
Rating Summary:
7 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
7 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade MHP Now!
Jefferies maintains a 'Buy' on McGraw-Hill (NYSE: MHP) price target of $54.00.
Analyst, David Reynolds, said, "Speculation regarding Wood Mackenzie was resolved yesterday with the announcement that Hellman & Freidman stumped up US$1.7bn, more than x12 EBITDA, for the business...Never know how engaged prospective buyers were, but MHP's decision not to enter a bidding war should be applauded...MHP shareholders didn't like the prospective deal."
For an analyst ratings summary and ratings history on McGraw-Hill click here. For more ratings news on McGraw-Hill click here.
Shares of McGraw-Hill closed at $45.69 yesterday, with a 52 week range of $34.95-$50.00.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, David Reynolds, said, "Speculation regarding Wood Mackenzie was resolved yesterday with the announcement that Hellman & Freidman stumped up US$1.7bn, more than x12 EBITDA, for the business...Never know how engaged prospective buyers were, but MHP's decision not to enter a bidding war should be applauded...MHP shareholders didn't like the prospective deal."
For an analyst ratings summary and ratings history on McGraw-Hill click here. For more ratings news on McGraw-Hill click here.
Shares of McGraw-Hill closed at $45.69 yesterday, with a 52 week range of $34.95-$50.00.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Bausch & Lomb near deal to sell to Valeant Pharmaceuticals (VRX) - WSJ
- UPDATE: Chile regulators stopped build, imposed sanctions on Barrick Gold (ABX)
- Saks (SKS) Won't Comment on Tonight's Takeover 'Rumor'
Create E-mail Alert Related Categories
Analyst Comments, Mergers and Acquisitions, RumorsRelated Entities
Jefferies & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
